Corbus Pharmaceuticals Holdings, Inc.·4

Feb 15, 12:53 PM ET

Millian Craig Stuart 4

4 · Corbus Pharmaceuticals Holdings, Inc. · Filed Feb 15, 2023

Insider Transaction Report

Form 4
Period: 2023-02-13
Millian Craig Stuart
Chief Commercial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-02-13+934,645934,645 total
    Exercise: $0.14Exp: 2033-02-13Common Stock (934,645 underlying)
Footnotes (1)
  • [F1]The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 13 2024, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 13, 2024.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION